Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI™ ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients

被引:39
|
作者
Mazzaferro, Sandro [1 ]
Pasquali, Marzia [1 ]
Farcomeni, Alessio [2 ]
Vestri, Anna Rita [2 ]
Filippini, Angelo [3 ]
Romani, Anna Maria [3 ]
Barresi, Giusi [1 ]
Pugliese, Francesco [1 ]
机构
[1] Sapienza Univ, Dept Clin Sci, I-00161 Rome, Italy
[2] Sapienza Univ, Dept Expt Med, I-00161 Rome, Italy
[3] Sapienza Univ, Dept Surg Sci, I-00161 Rome, Italy
关键词
NKF-K/DOQI guidelines; parathyroid hormone; parathytroidectomy; secondary hyperparathyroidism;
D O I
10.1093/ndt/gfm931
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. The recommended NKF-K/DOQI'99 ranges for Ca, P and PTH in dialysis seem advisable also for patients previously submitted to parathyroidectomy; however no paper addresses, specifically in this condition, to what extent optimal values are targeted in the short and long term after surgery. Methods. We checked serum Ca, P and PTH basally and after 1 month and 1, 3 and 5 years since surgery, in 77 dialysis subjects who received parathyroidectomy in our hospital. Results. Immediately after surgery all biochemical para- meters dropped, but afterwards Ca showed a tendency to increase progressively in the long term (p <.0006), P increased mostly within one year (p <.01), and PTH increased similarly to Ca (p <.003), but with mean values always in the lower than desired range. The estimated percentage of patients at target during the follow-up was maximal for P (values between 65 and 76%), lower for Ca (zenith of 43% after 1 month but declining down to 14% after 5 years) and minimal for PTH (invariably < 10%). Persistence within the ranges (at least on two consecutive checks) was 21% after one month for Ca, with a tendency to reduction; 41% for P, with a tendency to average roughly 30%, and practically zero for PTH. Neither type of surgery (total or subtotal) nor vitamin D therapy were associated with the low values of PTH observed. Conclusions. We conclude that parathyroid surgery does not represent an optimal therapeutic tool for targeting the recommended ranges for Ca, P and PTH. In particular, too low PTH values are frequently obtained, whose clinical effects deserve further studies. The possibility of a time dependent risk for recurrence is confirmed.
引用
收藏
页码:2319 / 2323
页数:5
相关论文
共 39 条
  • [21] Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
    Chia-Te Liao
    Cai-Mei Zheng
    Yen-Chung Lin
    Mei-Yi Wu
    Yuh-Feng Lin
    Yung-Ho Hsu
    Chih-Cheng Hsu
    Mai-Szu Wu
    Scientific Reports, 12
  • [22] Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism
    Wan, Jinnan
    Li, Wenhuan
    Zhong, Yuan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (03)
  • [23] Restoration of Parathyroid Function After Change of Phosphate Binder From Calcium Carbonate to Lanthanum Carbonate in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone
    Inaba, Masaaki
    Okuno, Senji
    Nagayama, Harumi
    Yamada, Shinsuke
    Ishimura, Eiji
    Imanishi, Yasuo
    Shoji, Shigeichi
    JOURNAL OF RENAL NUTRITION, 2015, 25 (02) : 242 - 246
  • [24] Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients
    Movilli, Ezio
    Camerini, Corrado
    Gaggia, Paola
    Poiatti, Patrizia
    Pola, Alessandra
    Viola, Battista Fabio
    Zubani, Roberto
    Jeannin, Guido
    Cancarini, Giovanni
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (12) : 4032 - 4037
  • [25] Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients (vol 11, 1171, 2021)
    Liao, Chia-Te
    Zheng, Cai-Mei
    Lin, Yen-Chung
    Wu, Mei-Yi
    Lin, Yuh-Feng
    Hsu, Yung-Ho
    Hsu, Chih-Cheng
    Wu, Mai-Szu
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [26] Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis
    Murashima, Miho
    Fujii, Naohiko
    Goto, Shunsuke
    Hasegawa, Takeshi
    Abe, Masanori
    Hanafusa, Norio
    Fukagawa, Masafumi
    Hamano, Takayuki
    CLINICAL KIDNEY JOURNAL, 2023, 16 (11) : 1957 - 1964
  • [27] Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity
    Frazao, J. M.
    Messa, P.
    Mellotte, G. J.
    Geiger, H.
    Hagen, E. C.
    Quarles, L. D.
    Kerr, P. G.
    Banos, A.
    Dehmel, B.
    Urena, P.
    CLINICAL NEPHROLOGY, 2011, 76 (03) : 233 - 243
  • [28] Effect of low-calcium and standard-calcium dialysate on serum calcium, phosphorus and full-segment parathyroid hormone in patients on peritoneal dialysis: A retrospective observational study
    An, Ning
    Zhou, Haishan
    Li, Xianhui
    Yu, Xinyin
    Yang, Haijuan
    Zhai, Liping
    Huang, Yuhua
    Yao, Cuiwei
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2023, 46 (10-11): : 539 - 546
  • [29] Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function
    Kanbay, Mehmet
    Isik, Bunyamin
    Akcay, Ali
    Ozkara, Adem
    Karakurt, Feridun
    Turgut, Faruk
    Alkan, Rabia
    Uz, Ebru
    Bavbek, Nuket
    Yigitoglu, Ramazan
    Covic, Adrian
    AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (05) : 516 - 521
  • [30] THE EFFECTS OF PHOSPHATE BINDER DOSE (PBD) AND PARATHYROID-HORMONE (PTH) ON SERUM ALUMINUM LEVELS (SAL) IN PEDIATRIC MAINTENANCE (M) DIALYSIS PATIENTS (DP)
    POLINSKY, MS
    KAISER, BA
    ROOT, AW
    SRINIVASAN, R
    BALUARTE, HJ
    GRUSKIN, AB
    PEDIATRIC RESEARCH, 1986, 20 (04) : A456 - A456